OR WAIT null SECS
Coadministration of zuranolone with a standard antidepressant yields positive outcomes.
Sagar Parikh, MD, FRCPC, shares news about the CORAL Study examining zuranolone treatment in patients with major depressive disorder, which demonstrated a rapid and statistically significant reduction in depressive symptoms at day 3 and over the 2-week treatment period.
To read more about this study, see: Improving Depression Symptoms: Study Meets Endpoints.
Dr Parikh is a professor of Depression and Clinical Neuroscience, and Psychiatry Sciences, at the University of Michigan.